These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17596614)

  • 1. Albuterol inhalers.
    Gross NJ
    N Engl J Med; 2007 Jun; 356(26):2749; author reply 2749. PubMed ID: 17596614
    [No Abstract]   [Full Text] [Related]  

  • 2. Final count down to hfa albuterol inhalers: are we ready as yet?
    Butt AT; Kamat D; Pansare M
    Clin Pediatr (Phila); 2009 Mar; 48(2):131-4. PubMed ID: 19015282
    [No Abstract]   [Full Text] [Related]  

  • 3. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants.
    Hendeles L; Colice GL; Meyer RJ
    N Engl J Med; 2007 Mar; 356(13):1344-51. PubMed ID: 17392304
    [No Abstract]   [Full Text] [Related]  

  • 4. Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol.
    DeCanio SJ; Norman CS
    J Environ Manage; 2007 Oct; 85(1):1-8. PubMed ID: 16982135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic effect of the hydrofluoroalkane albuterol transition on children with asthma.
    Leo HL; Dombkowski KJ; Clark NM
    J Allergy Clin Immunol; 2008 Mar; 121(3):776-7. PubMed ID: 18328895
    [No Abstract]   [Full Text] [Related]  

  • 6. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFC Phase-Out and the Chiesi Solution.
    Huchon G; Fabbri LM
    Respiration; 2005; 72 Suppl 1():1-2. PubMed ID: 15915005
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA approves new inhaler without CFCs.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692883
    [No Abstract]   [Full Text] [Related]  

  • 9. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFA inhalers.
    Koninck JC; Magro P; Khanjari F; Lemarié E; Diot P
    Pediatr Pulmonol Suppl; 2004; 26():23-5. PubMed ID: 15029583
    [No Abstract]   [Full Text] [Related]  

  • 11. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A switch to eco-friendly inhalers.
    Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):2. PubMed ID: 19370797
    [No Abstract]   [Full Text] [Related]  

  • 13. Overcoming dose-counting mechanisms on metered-dose inhalers for urgent treatment in the operating room.
    Templeton LB; Galyon SW; Smith TE
    Anesth Analg; 2009 Nov; 109(5):1709-10. PubMed ID: 19843820
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing aerosol delivery by pressurized metered-dose inhalers.
    Rubin BK; Fink JB
    Respir Care; 2005 Sep; 50(9):1191-200. PubMed ID: 16122402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Now that CFC inhalers for asthma are being pulled off the market, what type of inhalers are replacing them?
    Mayo Clin Womens Healthsource; 2008 Nov; 12(11):8. PubMed ID: 18836401
    [No Abstract]   [Full Text] [Related]  

  • 17. Final rule on albuterol inhalers.
    FDA Consum; 2005; 39(4):3. PubMed ID: 16255065
    [No Abstract]   [Full Text] [Related]  

  • 18. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
    Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ozone-depleting substances; removal of essential-use designations. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Apr; 70(63):17167-92. PubMed ID: 15806739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition.
    Peters S
    Clin Cornerstone; 2009; 9(3):50-3. PubMed ID: 19781516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.